Commit
•
7ce48d8
1
Parent(s):
8c5250f
Update README.md (#4)
Browse files- Update README.md (0eed7e57ce365a868257ce04d93d9276fd6703d8)
Co-authored-by: Rhaiem <DhiyaEddine@users.noreply.huggingface.co>
README.md
CHANGED
@@ -116,7 +116,7 @@ We report in the following table our internal pipeline benchmarks:
|
|
116 |
<td>MMLU-PRO (5-shot)</td>
|
117 |
<td>32.4%</td>
|
118 |
<td>31.6%</td>
|
119 |
-
<td
|
120 |
<td>29.6%</td>
|
121 |
<td>26.3%</td>
|
122 |
</tr>
|
@@ -124,7 +124,7 @@ We report in the following table our internal pipeline benchmarks:
|
|
124 |
<td>IFEval</td>
|
125 |
<td>69.9%</td>
|
126 |
<td>65.7%</td>
|
127 |
-
<td
|
128 |
<td>78.6%</td>
|
129 |
<td>71.7%</td>
|
130 |
</tr>
|
@@ -141,7 +141,7 @@ We report in the following table our internal pipeline benchmarks:
|
|
141 |
<td>MATH(4-shot)</td>
|
142 |
<td>-</td>
|
143 |
<td>6.9%</td>
|
144 |
-
<td
|
145 |
<td>-</td>
|
146 |
<td>27.3%</td>
|
147 |
</tr>
|
@@ -158,7 +158,7 @@ We report in the following table our internal pipeline benchmarks:
|
|
158 |
<td>GPQA (0-shot)</td>
|
159 |
<td>10.3%</td>
|
160 |
<td>11.1%</td>
|
161 |
-
<td
|
162 |
<td>2.4%</td>
|
163 |
<td>7.2%</td>
|
164 |
</tr>
|
@@ -166,7 +166,7 @@ We report in the following table our internal pipeline benchmarks:
|
|
166 |
<td>MUSR (0-shot)</td>
|
167 |
<td>8.2%</td>
|
168 |
<td>12.2%</td>
|
169 |
-
<td
|
170 |
<td>8.4%</td>
|
171 |
<td>8.3%</td>
|
172 |
</tr>
|
@@ -174,7 +174,7 @@ We report in the following table our internal pipeline benchmarks:
|
|
174 |
<td>BBH (3-shot)</td>
|
175 |
<td>33.3%</td>
|
176 |
<td>35.3%</td>
|
177 |
-
<td
|
178 |
<td>29.9%</td>
|
179 |
<td>25.2%</td>
|
180 |
</tr>
|
|
|
116 |
<td>MMLU-PRO (5-shot)</td>
|
117 |
<td>32.4%</td>
|
118 |
<td>31.6%</td>
|
119 |
+
<td>31.6%</td>
|
120 |
<td>29.6%</td>
|
121 |
<td>26.3%</td>
|
122 |
</tr>
|
|
|
124 |
<td>IFEval</td>
|
125 |
<td>69.9%</td>
|
126 |
<td>65.7%</td>
|
127 |
+
<td>56.8%</td>
|
128 |
<td>78.6%</td>
|
129 |
<td>71.7%</td>
|
130 |
</tr>
|
|
|
141 |
<td>MATH(4-shot)</td>
|
142 |
<td>-</td>
|
143 |
<td>6.9%</td>
|
144 |
+
<td>9.44%</td>
|
145 |
<td>-</td>
|
146 |
<td>27.3%</td>
|
147 |
</tr>
|
|
|
158 |
<td>GPQA (0-shot)</td>
|
159 |
<td>10.3%</td>
|
160 |
<td>11.1%</td>
|
161 |
+
<td>6.4%</td>
|
162 |
<td>2.4%</td>
|
163 |
<td>7.2%</td>
|
164 |
</tr>
|
|
|
166 |
<td>MUSR (0-shot)</td>
|
167 |
<td>8.2%</td>
|
168 |
<td>12.2%</td>
|
169 |
+
<td>7.4%</td>
|
170 |
<td>8.4%</td>
|
171 |
<td>8.3%</td>
|
172 |
</tr>
|
|
|
174 |
<td>BBH (3-shot)</td>
|
175 |
<td>33.3%</td>
|
176 |
<td>35.3%</td>
|
177 |
+
<td>37.8%</td>
|
178 |
<td>29.9%</td>
|
179 |
<td>25.2%</td>
|
180 |
</tr>
|